These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23869492)

  • 21. Prevention of DNA damage in renal transplantation by losartan and enalapril: the role of renin-angiotensin system polymorphisms.
    Ghorbanihaghjo A; Veisi P; Argani H; Aghaeishahsavari M; Noroozianavval M; Rashtchizadeh N; Mesgari M; Safa J; Babaei H
    Clin Exp Nephrol; 2008 Feb; 12(1):65-73. PubMed ID: 18175066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis of randomized controlled trials comparing telmisartan with losartan in the treatment of patients with hypertension.
    Xi GL; Cheng JW; Lu GC
    Am J Hypertens; 2008 May; 21(5):546-52. PubMed ID: 18437146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic inhibition of the renin-angiotensin system did not attenuate hepatic toxicity induced by carbon tetrachloride in rats.
    Ekor M; Odewabi AO; Kale OE; Oritogun KS; Adesanoye OA; Bamidele TO
    Hum Exp Toxicol; 2011 Nov; 30(11):1840-8. PubMed ID: 21357630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renin-angiotensin system blockade is renoprotective in immune complex-mediated glomerulonephritis.
    Guo S; Kowalewska J; Wietecha TA; Iyoda M; Wang L; Yi K; Spencer M; Banas M; Alexandrescu S; Hudkins KL; Alpers CE
    J Am Soc Nephrol; 2008 Jun; 19(6):1168-76. PubMed ID: 18337487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of anemia in patients with type II diabetes and mild to moderate chronic kidney disease and the impact of anti-RAS medications.
    Dousdampanis P; Trigka K; Fourtounas C
    Saudi J Kidney Dis Transpl; 2014 May; 25(3):552-7. PubMed ID: 24821151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease.
    Frimodt-Møller M; Høj Nielsen A; Strandgaard S; Kamper AL
    Nephrol Dial Transplant; 2010 Mar; 25(3):842-7. PubMed ID: 19903661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
    Avanza AC; El Aouar LM; Mill JG
    Arq Bras Cardiol; 2000 Feb; 74(2):103-17. PubMed ID: 10904284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Losartan versus enalapril in the reduction of left ventricular hypertrophy secondary to systemic arterial hypertension].
    Uribe Flores JD; Hernández Jácome M; Guevara Dondé J; Segura X
    Arch Cardiol Mex; 2004; 74(3):192-9. PubMed ID: 15559871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conservative management of chronic kidney disease stage 5: role of angiotensin converting enzyme inhibitors.
    Dattolo PC; Gallo P; Michelassi S; Paudice N; Cannavò R; Romoli E; Fani F; Tsalouchos A; Mehmetaj A; Ferro G; Sisca S; Pizzarelli F
    J Nephrol; 2016 Dec; 29(6):809-815. PubMed ID: 27015900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effect of enalapril and losartan in conjunction with surgical coronary revascularisation versus revascularisation alone on systemic endothelial function.
    Trevelyan J; Needham EW; Morris A; Mattu RK
    Heart; 2005 Aug; 91(8):1053-7. PubMed ID: 16020596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency.
    Mackie FE; Meyer TW; Campbell DJ
    Kidney Int; 2002 Feb; 61(2):555-63. PubMed ID: 11849396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of uric acid-lowering therapy on the progression of chronic kidney disease: a systematic review and meta-analysis.
    Liu X; Zhai T; Ma R; Luo C; Wang H; Liu L
    Ren Fail; 2018 Nov; 40(1):289-297. PubMed ID: 29619870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT1 receptor expression as measured with PET imaging.
    Ismail B; deKemp RA; Croteau E; Hadizad T; Burns KD; Beanlands RS; DaSilva JN
    PLoS One; 2017; 12(5):e0177451. PubMed ID: 28542215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.
    Lacourcière Y; Bélanger A; Godin C; Hallé JP; Ross S; Wright N; Marion J
    Kidney Int; 2000 Aug; 58(2):762-9. PubMed ID: 10916100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COMPARISON OF LOSARTAN AND ENALAPRIL EFFECTS ON RENAL FUNCTION IN HYPERTENSIVE ADULTS WITH CHRONIC KIDNEY DISEASE AT A KENYAN REFERRAL HOSPITAL.
    Mugendi GA; Nyamu DG; Okalebo FA; Nyamweya NN; Ndwiga S; Mwangi M
    East Afr Med J; 2014 Apr; 91(4):125-32. PubMed ID: 26859031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of telmisartan and enalapril on renoprotection in patients with mild to moderate chronic kidney disease.
    Nakamura T; Fujiwara N; Kawagoe Y; Sugaya T; Ueda Y; Koide H
    Eur J Clin Invest; 2010 Sep; 40(9):790-6. PubMed ID: 20584070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
    Weir MR; Bakris GL; Gross C; Mayo MR; Garza D; Stasiv Y; Yuan J; Berman L; Williams GH
    Kidney Int; 2016 Sep; 90(3):696-704. PubMed ID: 27350174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal function in one-kidney, one clip sodium-restricted rats: influence of enalapril and losartan.
    Demeilliers B; Jover B; Mimran A
    J Hypertens; 1995 Dec; 13(12 Pt 2):1764-6. PubMed ID: 8903648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal protection of losartan 50 mg in normotensive Chinese patients with nondiabetic chronic kidney disease.
    Shen PC; He LQ; Yang XJ; Cao HX
    J Investig Med; 2012 Oct; 60(7):1041-7. PubMed ID: 22914601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.